Your browser doesn't support javascript.
loading
Retraction Note: Azoramide, a novel regulator, favors adipogenesis against osteogenesis through inhibiting the GLP-1 receptor-PKA-ß-catenin pathway.
Ruan, Banjun; Zhu, Zheng; Yan, Zhao; Yang, Wei; Zhai, Dongsheng; Wang, Li; Ye, Zichen; Lu, Huanyu; Xiang, An; Liang, Jingwei; Jiang, Yinghao; Xu, Chengming; Wang, Zhenyu; Wei, Ming; Lei, Xiaoying; Cao, Xiaorui; Lu, Zifan.
Affiliation
  • Ruan B; State Key Laboratory of Cancer Biology, Department of Pharmacogenomics, Fourth Military Medical University, Xi'an, 710032, People's Republic of China.
  • Zhu Z; Institute of Urinary Surgery, Xijing Hospital, Fourth Military Medical, University, Xi'an, 710032, People's Republic of China.
  • Yan Z; Institute of Orthopedic Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, 710032, People's Republic of China.
  • Yang W; Infection and Immunity Program, Department of Microbiology, Biomedicine Discovery Institute, Monash University, Clayton, VIC, 3800, Australia.
  • Zhai D; State Key Laboratory of Cancer Biology, Department of Pharmacogenomics, Fourth Military Medical University, Xi'an, 710032, People's Republic of China.
  • Wang L; State Key Laboratory of Cancer Biology, Department of Pharmacogenomics, Fourth Military Medical University, Xi'an, 710032, People's Republic of China.
  • Ye Z; State Key Laboratory of Cancer Biology, Department of Pharmacogenomics, Fourth Military Medical University, Xi'an, 710032, People's Republic of China.
  • Lu H; Department of Occupational and Environmental Health and the Ministry of Education Key Lab of Hazard Assessment and Control in Special Operational Environment, School of Public Health, Fourth Military Medical University, Xi'an, 710032, People's Republic of China.
  • Xiang A; State Key Laboratory of Cancer Biology, Department of Pharmacogenomics, Fourth Military Medical University, Xi'an, 710032, People's Republic of China.
  • Liang J; School of Pharmacy, China Medical University, Liaoning, 110122, China.
  • Jiang Y; State Key Laboratory of Cancer Biology, Department of Pharmacogenomics, Fourth Military Medical University, Xi'an, 710032, People's Republic of China.
  • Xu C; State Key Laboratory of Cancer Biology, Department of Pharmacogenomics, Fourth Military Medical University, Xi'an, 710032, People's Republic of China.
  • Wang Z; State Key Laboratory of Cancer Biology, Department of Pharmacogenomics, Fourth Military Medical University, Xi'an, 710032, People's Republic of China.
  • Wei M; Department of Pharmacology, Xi'an Medical University, Xi'an, 710021, People's Republic of China.
  • Lei X; State Key Laboratory of Cancer Biology, Department of Pharmacogenomics, Fourth Military Medical University, Xi'an, 710032, People's Republic of China.
  • Cao X; Institute of Orthopedic Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, 710032, People's Republic of China. caoxr528@sohu.com.
  • Lu Z; State Key Laboratory of Cancer Biology, Department of Pharmacogenomics, Fourth Military Medical University, Xi'an, 710032, People's Republic of China. luzfliuq@fmmu.edu.cn.
Stem Cell Res Ther ; 14(1): 275, 2023 Sep 29.
Article in En | MEDLINE | ID: mdl-37775775
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Stem Cell Res Ther Year: 2023 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Stem Cell Res Ther Year: 2023 Document type: Article